This study is in progress, not accepting new patients
Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults
Summary
- Eligibility
- for people ages 18-130 (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- Links
- Statistical Analysis Plan (SAP) D8110C00001-CSP-amendment-6_Redacted.pdf CSR Synopsis
- ID
- NCT04516746
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 32459 people participating
- Last Updated